ABUS SCHEDULE 13G: SEC filing

Filed with the SEC on · accession 0000905148-26-004887

ABUS filed a SCHEDULE 13G (schedule 13g) with the SEC on Nov 16, 2026. Nomura Holdings Inc. and its subsidiary Nomura Global Financial Products Inc. filed a Schedule 13G disclosing beneficial ownership of 14,512,000 common shares, or 7.3%, of Arbutus Biopharma Corp as of September 30, 2026. The stock moved -1.2% by the first close after the filing.

Summary of the filing

Nomura Holdings Inc. and its subsidiary Nomura Global Financial Products Inc. filed a Schedule 13G disclosing beneficial ownership of 14,512,000 common shares, or 7.3%, of Arbutus Biopharma Corp as of September 30, 2026. The filing is a passive investment disclosure under Rule 13d-1(b).

Key details

Common shares beneficially owned$14.5M
Percent of class ownedPCT 7
Filer / beneficial ownerNomura Holdings Inc.
Wholly owned subsidiary of nomura holdings inc. / direct beneficial ownerNomura Global Financial Products Inc.
IssuerArbutus Biopharma Corp
Managing director, nomura holdings inc.Samir Patel

How ABUS stock reacted

Close before

$4.09

Nov 13, 2026

First close after

-1.22%

$4.04

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for ABUS, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for ABUS?

Click here

Frequently asked questions

What did ABUS file with the SEC on Nov 16, 2026?

ABUS filed a SCHEDULE 13G (SEC filing). Nomura Holdings Inc. and its subsidiary Nomura Global Financial Products Inc. filed a Schedule 13G disclosing beneficial ownership of 14,512,000 common shares, or 7.3%, of Arbutus Biopharma Corp as of September 30, 2026. The filing is a passive investment disclosure under Rule 13d-1(b).

How do I read a SCHEDULE 13G?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).

How did ABUS stock react to this filing?

ABUS closed at $4.09 before the filing and $4.04 on Nov 16, 2026 (-1.22%).

Other ABUS SEC filings

Get alerts when ABUS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days